© 2019 transcendent pathology

11100 Endeavor Court, Suite 133

Manassas, VA 20109

Tel: 571-458-7797

  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon

About Us

About Transcendent Pathology

Our purpose is to help your team to Transcend Pathology!  The mission of Transcendent Pathology is to provide medical expertise services and support for clinical, research, education and leadership endeavors.  We assist client organizations in their initiation, coordination, strategy, implementation, and documentation of biomedical and biotechnology research projects covering multidisciplinary aspects of medical care in the veterinary and human healthcare sectors.

 

Additionally, we have specific expertise in research areas including cancer, women’s health, environmental toxicology and health, reproductive and developmental health.   Our toxicologic pathologists offer premier services for the conduct and management of research studies of varying complexities in biomedical research, medical device innovations, and biotechnology.  We consult on research design, strategy development, quality control, digital image analysis, molecular diagnostics, and animal welfare issues.  

Providing you with the best doctors for the best service

Gerelyn A. Henry, BS, DVM, MBA, DACFE

Dr. Gerelyn A. Henry is the Founder and CEO of Transcendent Pathology.   Dr. Henry is a residency- and fellowship-trained veterinary physician scientist, medical executive, translational medicine professional, and is a fellow of the American College of Forensic Examiners.  Dr. Henry has a Global Executive MBA from the University of Virginia, and is the former Deputy Director of the Tulane-Xavier Center of Excellence in Women’s Health, and Immunohistochemistry Section Chief of the Tuskegee University College of Veterinary Medicine Diagnostic Laboratory.  Dr. Henry has deep experience in developmental and reproductive toxicologic pathology and human carcinogenesis.  She has worked in pre-clinical safety assessment on numerous projects in the public and private sectors for small and large pharmaceutical and biotechnology companies.  Dr. Henry is licensed to practice veterinary medicine in Virginia, Maryland, Georgia and Alabama; and is a USDA Accredited Veterinarian, II.  Dr. Henry has an energetic bedside manner and is passionate about educating clients on the clinical significance of pathology testing, and translating research findings and information into valuable use in patients.

Athema L. Etzioni, BS, DVM, MS, DACVP

Dr. Athema L. Etzioni is Managing Director of Veterinary Clinical Pathology for Transcendent Pathology.  Dr. Etzioni is a Board-certified, residency-trained Veterinary Clinical Pathologist with a Master’s degree in Pathology from Purdue University,   Dr. Etzioni offers considerable expertise to our clients in all aspects of hematology, clinical chemistry, cytology and body fluid analysis, and brings her extensive clinical experience to bear when evaluating clinical pathology data from various cases or species-specific research studies.  In addition, she has worked in academia, research, government, corporate and private sectors of veterinary medicine.  Dr. Etzioni has experience as a collaborative partner with researchers, assisting in clinical pathology studies and interpreting data endpoints.  She also has experience in histochemistry, and anatomic pathology research.  Dr. Etzioni is licensed to practice veterinary medicine, and is an USDA Accredited Veterinarian, II.  She has interests in all aspects of diagnostic clinical pathology and clinical veterinary medicine, and has an engaging and charismatic manner when working with clients. 

Angela K. Brice, DVM, PhD, DACVP

Dr. Angela K. Brice is Managing Director of Laboratory Animal Pathology Services for Transcendent Pathology.  Dr. Brice completed postdoctoral training in Comparative Pathology and obtained a Ph.D. in Cellular and Molecular Medicine from Johns Hopkins University. She is a Diplomate of the American College of Veterinary Pathology.  Her graduate research work was conducted in the John’s Hopkin’s School of Medicine HIV Retrovirus laboratory, and her thesis focused on the immune-modulatory properties of minocycline and more specifically, the mechanism of action of minocycline’s effect on CD4+ T cell activation, proliferation and cell cycle progression.  Dr. Brice’s subspecialty and professional interests are the pathology of animal models used in biomedical research, teaching and training. She brings extensive experience in the diagnostic pathology of laboratory animals such as mice (including genetically-engineered mice), rats, nonhuman primates, dogs, sheep, pig, aquatic and avian species. She also collaborates with principal investigators assisting in aspects of research projects including experimental design, mouse phenotyping, and grading and interpreting lesions. 

The Best Team To Support Your Endeavors!

Ms. Christina Wingate

Ms. Christina Wingate is the Director of Communications and Marketing.  She is an avid writer and visual artist.  Christina is involved with hiring the best talent and communicating with stakeholders.

Ms. Elma Williams

Ms. Williams has over a decade of experience with histotechnology and serves as our histotechnologist. She has experience with immunohistochemistry and special staining techniques.

Our doctors offer valuable experience to clients and patients.  We are creating the future of diagnostic medicine.

Monique Y. Wells, BS, VMD, MS, DACVP, DECVP, DABT

 Dr. Monique Y. Wells is a Senior Veterinary Pathologist and Toxicologist with 28 years of experience in toxicologic pathology. She earned her doctorate in veterinary medicine from the University of Pennsylvania and her master’s degree in veterinary pathobiology from The Ohio State University. Dr. Wells is a diplomate of the American College of Veterinary Pathologists, the European College of Veterinary Pathologists, and the American Board of Toxicology, and is also a Eurotox-registered toxicologist. 

Dr. Wells provides high level peer review, preclinical dossier review, and due diligence consulting services to our clients in private industry, governmental and NGO institutions. 

Marcus B. Iszard, BS, MS, PhD

Dr. Marcus B. Iszard is an expert research and practicing Pharmacologist and Toxicologist and is a Fellow of the National Board of Osteopathic Medical Examiners. He has extensive experience with basic and applied pharmacology research, drug metabolism, pharmacokinetics, therapeutic/patient clinical assessment and quality teaching presentations. He provides consulting and investigation services for law enforcement agencies and private/corporate law firms for criminal or civil legal matters. His professional experience is based primarily in matters involving medical pharmacology and toxicology as a drug, poison pharmaceutical expert. Dr. Iszard has extensive knowledge in drug metabolism and pharmacokinetics. This experience allows high-level interpretation and construction of dose-response relationships, volume of distribution models and biotransformation of xenobiotics, drug disposition and modeling. 

Monty Banerjee, BS, MS, DVM, PhD

Dr. Monty Banerjee is a Senior Veterinary Pathologist with deep experience with industrial, commercial, academic, and government pathology.  Dr. Banerjee earned his PhD from Albany Medical College in Experimental Pathology and Molecular Biology, and completed post-doctoral fellowship training at the University of California at Davis CVM, and Michigan State University.  Dr. Banerjee conducts preclinical translational research and diagnostic pathology studies.  His areas of concentration are in cytology, histopathology, gross pathology, immunohistochemistry, in-situ hybridization and TUNEL assays. Dr. Banerjee conducts pathological analysis of all species of animals, birds and wildlife.  He develops laboratory QA/QC protocols and standard operating procedures, and has extensive experience leading bacteriology, virology, serology and toxicology teams.

Eusebio Pires, BS, MS, MBA, PhD

Dr. Eusebio S. Pires is the Managing Director of Translational Science Applications and Projects for Transcendent Pathology.  He is an award-winning Senior Research Scientist, with a dynamic, independent and multi-disciplinary research portfolio, focusing on methodological development of novel diagnostic and therapeutic approaches for treatment of cancers. He holds a PhD in Applied Biology, specializing in reproductive immunology, all from the University of Mumbai, Mumbai, India.  He completed a post-doctoral fellowship at The National Institute for Research in Reproductive Health, Mumbai, India, and subsequently was an NIH Fogarty International Center Fellow at the University of Virginia.  Dr. Pires is well versed with basic cell and reproductive biology, reproductive immunology and cancer translational medicine. At the University of Virginia School of Medicine, his team partnered and collaborated with biotechnology and pharmaceutical companies to develop and characterize targeted therapies, biological therapeutics, and bioengineered medical devices. Dr. Pires is an innovator and has expertise in multiple contemporary molecular biological and imaging technologies, and is a certified Executive Coach.

Crystal M. Briscoe, BS, DVM, DACVP, Ret. Col.

Dr. Crystal M. Briscoe, DACVP is a Senior Veterinary Pathologist with leadership and medical experience in military, commercial, veterinary, and government sectors.  Dr. Briscoe is the former Branch Chief of Comparative Pathology of the U.S. Army Medical Institute of Chemical Defense (USAMRICD), Aberdeen Proving Ground (Edgewood), Maryland and former Director of Laboratory Animal Medicine, Clinical Investigation and Research (Laboratory Resources) for the US Army, Pentagon at the Naval Medical Center in Portsmouth, Virginia. After completing her residency at the Armed Forces Institute of Pathology in Washington D. C., she was appointed as Chief of Necropsy Services and Ultrastructual Pathology at U.S. Army, Walter Reed Army Institute Of Research. Dr. Briscoe served as study pathologist for acute, sub-chronic, and chronic toxicological studies for trials conducted in conjunction with the National Toxicology Program (NTP), and a variety of pharmaceutical industrial clients.  Her expertise includes infectious disease pathology, diagnostic anatomical pathology, cytology, laboratory animal medicine, and toxicological pathology (including carcinogenicity studies).  Dr. Briscoe is licensed to practice veterinary medicine and surgery in Virginia.